Global Legionella Testing

Legionella Testing Comprehensive Study by Type (Microbial Culture, DFA Stain, PCR, Others), Application (Water Testing, IVD Testing), End User (Hospital and Clinic, Diagnostic Laboratory) Players and Region - Global Market Outlook to 2030

Legionella Testing Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Legionella Testing
Legionella is a type of bacteria that can cause a serious form of pneumonia called Legionnaires disease. A legionella infection affects the lower respiratory tract, often requires hospitalization, and has a significant mortality rate. In addition to pneumonia, Legionella bacteria can also cause Pontiac fever, a milder and self-limiting illness with flu-like symptoms (without pneumonia). Together, Legionnaires disease and Pontiac fever are referred to as legionellosis. Legionella testing detects the presence of the bacteria or parts of it (antigens) to help diagnose the cause of a person's pneumonia.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Legionella Testing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Beckman Coulter (United States), Bio-Rad Laboratories (United States), Abbott (United States), Roche Diagnostics (Switzerland), Thermo Fischer Scientific(United States), Becton, Dickinson (BD) (United States), BioMerieux(France), Eiken Chemical(Japan), Hologic (United States) and Pro-lab Diagnostics(United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are QIAGEN (United States) and Takara Bio(Japan).

Segmentation Overview
AMA Research has segmented the market of Global Legionella Testing market by Type (Microbial Culture, DFA Stain, PCR and Others), Application (Water Testing and IVD Testing) and Region.



On the basis of geography, the market of Legionella Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospital and Clinic will boost the Legionella Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancements in the Field of Bacterial Testing

Market Growth Drivers:
Pneumonia and Legionella-related illnesses are becoming more common and Rapid and Advanced Diagnostic Techniques are in High Demand

Challenges:
Insufficient Disposable Income

Restraints:
Concern about the sensitivity of diagnostic tests

Opportunities:
Increasing spending on the healthcare system in developing regions

Market Leaders and their expansionary development strategies
In December 2021, Pace Analytical Services, a division of Pace Science and Technology Company, and preferred provider of in-lab, mobile, and emergency onsite specialty-contaminant and regulatory testing and analysis services, today announced that it has acquired Special Pathogens Laboratory, the market leader in Legionella testing, detection, remediation, and prevention.
in July 2021, Phigenics announced the launch of a new detection tool, Phigenics Validation Test, which combines the PCR and culture methods to quickly detect all types of legionella bacteria in waterbodies within 72 hours.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Legionella Testing Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Microbial Culture
  • DFA Stain
  • PCR
  • Others
By Application
  • Water Testing
  • IVD Testing
By End User
  • Hospital and Clinic
  • Diagnostic Laboratory

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Pneumonia and Legionella-related illnesses are becoming more common
      • 3.2.2. Rapid and Advanced Diagnostic Techniques are in High Demand
    • 3.3. Market Challenges
      • 3.3.1. Insufficient Disposable Income
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Field of Bacterial Testing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Legionella Testing, by Type, Application, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Legionella Testing (Value)
      • 5.2.1. Global Legionella Testing by: Type (Value)
        • 5.2.1.1. Microbial Culture
        • 5.2.1.2. DFA Stain
        • 5.2.1.3. PCR
        • 5.2.1.4. Others
      • 5.2.2. Global Legionella Testing by: Application (Value)
        • 5.2.2.1. Water Testing
        • 5.2.2.2. IVD Testing
      • 5.2.3. Global Legionella Testing by: End User (Value)
        • 5.2.3.1. Hospital and Clinic
        • 5.2.3.2. Diagnostic Laboratory
      • 5.2.4. Global Legionella Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Legionella Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Beckman Coulter (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Roche Diagnostics (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fischer Scientific(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton, Dickinson (BD) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMerieux(France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eiken Chemical(Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hologic (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pro-lab Diagnostics(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Legionella Testing Sale, by Type, Application, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Legionella Testing (Value)
      • 7.2.1. Global Legionella Testing by: Type (Value)
        • 7.2.1.1. Microbial Culture
        • 7.2.1.2. DFA Stain
        • 7.2.1.3. PCR
        • 7.2.1.4. Others
      • 7.2.2. Global Legionella Testing by: Application (Value)
        • 7.2.2.1. Water Testing
        • 7.2.2.2. IVD Testing
      • 7.2.3. Global Legionella Testing by: End User (Value)
        • 7.2.3.1. Hospital and Clinic
        • 7.2.3.2. Diagnostic Laboratory
      • 7.2.4. Global Legionella Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Legionella Testing: by Type(USD Million)
  • Table 2. Legionella Testing Microbial Culture , by Region USD Million (2018-2023)
  • Table 3. Legionella Testing DFA Stain , by Region USD Million (2018-2023)
  • Table 4. Legionella Testing PCR , by Region USD Million (2018-2023)
  • Table 5. Legionella Testing Others , by Region USD Million (2018-2023)
  • Table 6. Legionella Testing: by Application(USD Million)
  • Table 7. Legionella Testing Water Testing , by Region USD Million (2018-2023)
  • Table 8. Legionella Testing IVD Testing , by Region USD Million (2018-2023)
  • Table 9. Legionella Testing: by End User(USD Million)
  • Table 10. Legionella Testing Hospital and Clinic , by Region USD Million (2018-2023)
  • Table 11. Legionella Testing Diagnostic Laboratory , by Region USD Million (2018-2023)
  • Table 12. South America Legionella Testing, by Country USD Million (2018-2023)
  • Table 13. South America Legionella Testing, by Type USD Million (2018-2023)
  • Table 14. South America Legionella Testing, by Application USD Million (2018-2023)
  • Table 15. South America Legionella Testing, by End User USD Million (2018-2023)
  • Table 16. Brazil Legionella Testing, by Type USD Million (2018-2023)
  • Table 17. Brazil Legionella Testing, by Application USD Million (2018-2023)
  • Table 18. Brazil Legionella Testing, by End User USD Million (2018-2023)
  • Table 19. Argentina Legionella Testing, by Type USD Million (2018-2023)
  • Table 20. Argentina Legionella Testing, by Application USD Million (2018-2023)
  • Table 21. Argentina Legionella Testing, by End User USD Million (2018-2023)
  • Table 22. Rest of South America Legionella Testing, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Legionella Testing, by Application USD Million (2018-2023)
  • Table 24. Rest of South America Legionella Testing, by End User USD Million (2018-2023)
  • Table 25. Asia Pacific Legionella Testing, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Legionella Testing, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Legionella Testing, by Application USD Million (2018-2023)
  • Table 28. Asia Pacific Legionella Testing, by End User USD Million (2018-2023)
  • Table 29. China Legionella Testing, by Type USD Million (2018-2023)
  • Table 30. China Legionella Testing, by Application USD Million (2018-2023)
  • Table 31. China Legionella Testing, by End User USD Million (2018-2023)
  • Table 32. Japan Legionella Testing, by Type USD Million (2018-2023)
  • Table 33. Japan Legionella Testing, by Application USD Million (2018-2023)
  • Table 34. Japan Legionella Testing, by End User USD Million (2018-2023)
  • Table 35. India Legionella Testing, by Type USD Million (2018-2023)
  • Table 36. India Legionella Testing, by Application USD Million (2018-2023)
  • Table 37. India Legionella Testing, by End User USD Million (2018-2023)
  • Table 38. South Korea Legionella Testing, by Type USD Million (2018-2023)
  • Table 39. South Korea Legionella Testing, by Application USD Million (2018-2023)
  • Table 40. South Korea Legionella Testing, by End User USD Million (2018-2023)
  • Table 41. Taiwan Legionella Testing, by Type USD Million (2018-2023)
  • Table 42. Taiwan Legionella Testing, by Application USD Million (2018-2023)
  • Table 43. Taiwan Legionella Testing, by End User USD Million (2018-2023)
  • Table 44. Australia Legionella Testing, by Type USD Million (2018-2023)
  • Table 45. Australia Legionella Testing, by Application USD Million (2018-2023)
  • Table 46. Australia Legionella Testing, by End User USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Legionella Testing, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Legionella Testing, by Application USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Legionella Testing, by End User USD Million (2018-2023)
  • Table 50. Europe Legionella Testing, by Country USD Million (2018-2023)
  • Table 51. Europe Legionella Testing, by Type USD Million (2018-2023)
  • Table 52. Europe Legionella Testing, by Application USD Million (2018-2023)
  • Table 53. Europe Legionella Testing, by End User USD Million (2018-2023)
  • Table 54. Germany Legionella Testing, by Type USD Million (2018-2023)
  • Table 55. Germany Legionella Testing, by Application USD Million (2018-2023)
  • Table 56. Germany Legionella Testing, by End User USD Million (2018-2023)
  • Table 57. France Legionella Testing, by Type USD Million (2018-2023)
  • Table 58. France Legionella Testing, by Application USD Million (2018-2023)
  • Table 59. France Legionella Testing, by End User USD Million (2018-2023)
  • Table 60. Italy Legionella Testing, by Type USD Million (2018-2023)
  • Table 61. Italy Legionella Testing, by Application USD Million (2018-2023)
  • Table 62. Italy Legionella Testing, by End User USD Million (2018-2023)
  • Table 63. United Kingdom Legionella Testing, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Legionella Testing, by Application USD Million (2018-2023)
  • Table 65. United Kingdom Legionella Testing, by End User USD Million (2018-2023)
  • Table 66. Netherlands Legionella Testing, by Type USD Million (2018-2023)
  • Table 67. Netherlands Legionella Testing, by Application USD Million (2018-2023)
  • Table 68. Netherlands Legionella Testing, by End User USD Million (2018-2023)
  • Table 69. Rest of Europe Legionella Testing, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Legionella Testing, by Application USD Million (2018-2023)
  • Table 71. Rest of Europe Legionella Testing, by End User USD Million (2018-2023)
  • Table 72. MEA Legionella Testing, by Country USD Million (2018-2023)
  • Table 73. MEA Legionella Testing, by Type USD Million (2018-2023)
  • Table 74. MEA Legionella Testing, by Application USD Million (2018-2023)
  • Table 75. MEA Legionella Testing, by End User USD Million (2018-2023)
  • Table 76. Middle East Legionella Testing, by Type USD Million (2018-2023)
  • Table 77. Middle East Legionella Testing, by Application USD Million (2018-2023)
  • Table 78. Middle East Legionella Testing, by End User USD Million (2018-2023)
  • Table 79. Africa Legionella Testing, by Type USD Million (2018-2023)
  • Table 80. Africa Legionella Testing, by Application USD Million (2018-2023)
  • Table 81. Africa Legionella Testing, by End User USD Million (2018-2023)
  • Table 82. North America Legionella Testing, by Country USD Million (2018-2023)
  • Table 83. North America Legionella Testing, by Type USD Million (2018-2023)
  • Table 84. North America Legionella Testing, by Application USD Million (2018-2023)
  • Table 85. North America Legionella Testing, by End User USD Million (2018-2023)
  • Table 86. United States Legionella Testing, by Type USD Million (2018-2023)
  • Table 87. United States Legionella Testing, by Application USD Million (2018-2023)
  • Table 88. United States Legionella Testing, by End User USD Million (2018-2023)
  • Table 89. Canada Legionella Testing, by Type USD Million (2018-2023)
  • Table 90. Canada Legionella Testing, by Application USD Million (2018-2023)
  • Table 91. Canada Legionella Testing, by End User USD Million (2018-2023)
  • Table 92. Mexico Legionella Testing, by Type USD Million (2018-2023)
  • Table 93. Mexico Legionella Testing, by Application USD Million (2018-2023)
  • Table 94. Mexico Legionella Testing, by End User USD Million (2018-2023)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Legionella Testing: by Type(USD Million)
  • Table 106. Legionella Testing Microbial Culture , by Region USD Million (2025-2030)
  • Table 107. Legionella Testing DFA Stain , by Region USD Million (2025-2030)
  • Table 108. Legionella Testing PCR , by Region USD Million (2025-2030)
  • Table 109. Legionella Testing Others , by Region USD Million (2025-2030)
  • Table 110. Legionella Testing: by Application(USD Million)
  • Table 111. Legionella Testing Water Testing , by Region USD Million (2025-2030)
  • Table 112. Legionella Testing IVD Testing , by Region USD Million (2025-2030)
  • Table 113. Legionella Testing: by End User(USD Million)
  • Table 114. Legionella Testing Hospital and Clinic , by Region USD Million (2025-2030)
  • Table 115. Legionella Testing Diagnostic Laboratory , by Region USD Million (2025-2030)
  • Table 116. South America Legionella Testing, by Country USD Million (2025-2030)
  • Table 117. South America Legionella Testing, by Type USD Million (2025-2030)
  • Table 118. South America Legionella Testing, by Application USD Million (2025-2030)
  • Table 119. South America Legionella Testing, by End User USD Million (2025-2030)
  • Table 120. Brazil Legionella Testing, by Type USD Million (2025-2030)
  • Table 121. Brazil Legionella Testing, by Application USD Million (2025-2030)
  • Table 122. Brazil Legionella Testing, by End User USD Million (2025-2030)
  • Table 123. Argentina Legionella Testing, by Type USD Million (2025-2030)
  • Table 124. Argentina Legionella Testing, by Application USD Million (2025-2030)
  • Table 125. Argentina Legionella Testing, by End User USD Million (2025-2030)
  • Table 126. Rest of South America Legionella Testing, by Type USD Million (2025-2030)
  • Table 127. Rest of South America Legionella Testing, by Application USD Million (2025-2030)
  • Table 128. Rest of South America Legionella Testing, by End User USD Million (2025-2030)
  • Table 129. Asia Pacific Legionella Testing, by Country USD Million (2025-2030)
  • Table 130. Asia Pacific Legionella Testing, by Type USD Million (2025-2030)
  • Table 131. Asia Pacific Legionella Testing, by Application USD Million (2025-2030)
  • Table 132. Asia Pacific Legionella Testing, by End User USD Million (2025-2030)
  • Table 133. China Legionella Testing, by Type USD Million (2025-2030)
  • Table 134. China Legionella Testing, by Application USD Million (2025-2030)
  • Table 135. China Legionella Testing, by End User USD Million (2025-2030)
  • Table 136. Japan Legionella Testing, by Type USD Million (2025-2030)
  • Table 137. Japan Legionella Testing, by Application USD Million (2025-2030)
  • Table 138. Japan Legionella Testing, by End User USD Million (2025-2030)
  • Table 139. India Legionella Testing, by Type USD Million (2025-2030)
  • Table 140. India Legionella Testing, by Application USD Million (2025-2030)
  • Table 141. India Legionella Testing, by End User USD Million (2025-2030)
  • Table 142. South Korea Legionella Testing, by Type USD Million (2025-2030)
  • Table 143. South Korea Legionella Testing, by Application USD Million (2025-2030)
  • Table 144. South Korea Legionella Testing, by End User USD Million (2025-2030)
  • Table 145. Taiwan Legionella Testing, by Type USD Million (2025-2030)
  • Table 146. Taiwan Legionella Testing, by Application USD Million (2025-2030)
  • Table 147. Taiwan Legionella Testing, by End User USD Million (2025-2030)
  • Table 148. Australia Legionella Testing, by Type USD Million (2025-2030)
  • Table 149. Australia Legionella Testing, by Application USD Million (2025-2030)
  • Table 150. Australia Legionella Testing, by End User USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Legionella Testing, by Type USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Legionella Testing, by Application USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Legionella Testing, by End User USD Million (2025-2030)
  • Table 154. Europe Legionella Testing, by Country USD Million (2025-2030)
  • Table 155. Europe Legionella Testing, by Type USD Million (2025-2030)
  • Table 156. Europe Legionella Testing, by Application USD Million (2025-2030)
  • Table 157. Europe Legionella Testing, by End User USD Million (2025-2030)
  • Table 158. Germany Legionella Testing, by Type USD Million (2025-2030)
  • Table 159. Germany Legionella Testing, by Application USD Million (2025-2030)
  • Table 160. Germany Legionella Testing, by End User USD Million (2025-2030)
  • Table 161. France Legionella Testing, by Type USD Million (2025-2030)
  • Table 162. France Legionella Testing, by Application USD Million (2025-2030)
  • Table 163. France Legionella Testing, by End User USD Million (2025-2030)
  • Table 164. Italy Legionella Testing, by Type USD Million (2025-2030)
  • Table 165. Italy Legionella Testing, by Application USD Million (2025-2030)
  • Table 166. Italy Legionella Testing, by End User USD Million (2025-2030)
  • Table 167. United Kingdom Legionella Testing, by Type USD Million (2025-2030)
  • Table 168. United Kingdom Legionella Testing, by Application USD Million (2025-2030)
  • Table 169. United Kingdom Legionella Testing, by End User USD Million (2025-2030)
  • Table 170. Netherlands Legionella Testing, by Type USD Million (2025-2030)
  • Table 171. Netherlands Legionella Testing, by Application USD Million (2025-2030)
  • Table 172. Netherlands Legionella Testing, by End User USD Million (2025-2030)
  • Table 173. Rest of Europe Legionella Testing, by Type USD Million (2025-2030)
  • Table 174. Rest of Europe Legionella Testing, by Application USD Million (2025-2030)
  • Table 175. Rest of Europe Legionella Testing, by End User USD Million (2025-2030)
  • Table 176. MEA Legionella Testing, by Country USD Million (2025-2030)
  • Table 177. MEA Legionella Testing, by Type USD Million (2025-2030)
  • Table 178. MEA Legionella Testing, by Application USD Million (2025-2030)
  • Table 179. MEA Legionella Testing, by End User USD Million (2025-2030)
  • Table 180. Middle East Legionella Testing, by Type USD Million (2025-2030)
  • Table 181. Middle East Legionella Testing, by Application USD Million (2025-2030)
  • Table 182. Middle East Legionella Testing, by End User USD Million (2025-2030)
  • Table 183. Africa Legionella Testing, by Type USD Million (2025-2030)
  • Table 184. Africa Legionella Testing, by Application USD Million (2025-2030)
  • Table 185. Africa Legionella Testing, by End User USD Million (2025-2030)
  • Table 186. North America Legionella Testing, by Country USD Million (2025-2030)
  • Table 187. North America Legionella Testing, by Type USD Million (2025-2030)
  • Table 188. North America Legionella Testing, by Application USD Million (2025-2030)
  • Table 189. North America Legionella Testing, by End User USD Million (2025-2030)
  • Table 190. United States Legionella Testing, by Type USD Million (2025-2030)
  • Table 191. United States Legionella Testing, by Application USD Million (2025-2030)
  • Table 192. United States Legionella Testing, by End User USD Million (2025-2030)
  • Table 193. Canada Legionella Testing, by Type USD Million (2025-2030)
  • Table 194. Canada Legionella Testing, by Application USD Million (2025-2030)
  • Table 195. Canada Legionella Testing, by End User USD Million (2025-2030)
  • Table 196. Mexico Legionella Testing, by Type USD Million (2025-2030)
  • Table 197. Mexico Legionella Testing, by Application USD Million (2025-2030)
  • Table 198. Mexico Legionella Testing, by End User USD Million (2025-2030)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Legionella Testing: by Type USD Million (2018-2023)
  • Figure 5. Global Legionella Testing: by Application USD Million (2018-2023)
  • Figure 6. Global Legionella Testing: by End User USD Million (2018-2023)
  • Figure 7. South America Legionella Testing Share (%), by Country
  • Figure 8. Asia Pacific Legionella Testing Share (%), by Country
  • Figure 9. Europe Legionella Testing Share (%), by Country
  • Figure 10. MEA Legionella Testing Share (%), by Country
  • Figure 11. North America Legionella Testing Share (%), by Country
  • Figure 12. Global Legionella Testing share by Players 2023 (%)
  • Figure 13. Global Legionella Testing share by Players (Top 3) 2023(%)
  • Figure 14. Global Legionella Testing share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 17. Beckman Coulter (United States) Revenue: by Geography 2023
  • Figure 18. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bio-Rad Laboratories (United States) Revenue: by Geography 2023
  • Figure 20. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott (United States) Revenue: by Geography 2023
  • Figure 22. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Roche Diagnostics (Switzerland) Revenue: by Geography 2023
  • Figure 24. Thermo Fischer Scientific(United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fischer Scientific(United States) Revenue: by Geography 2023
  • Figure 26. Becton, Dickinson (BD) (United States) Revenue, Net Income and Gross profit
  • Figure 27. Becton, Dickinson (BD) (United States) Revenue: by Geography 2023
  • Figure 28. BioMerieux(France) Revenue, Net Income and Gross profit
  • Figure 29. BioMerieux(France) Revenue: by Geography 2023
  • Figure 30. Eiken Chemical(Japan) Revenue, Net Income and Gross profit
  • Figure 31. Eiken Chemical(Japan) Revenue: by Geography 2023
  • Figure 32. Hologic (United States) Revenue, Net Income and Gross profit
  • Figure 33. Hologic (United States) Revenue: by Geography 2023
  • Figure 34. Pro-lab Diagnostics(United States) Revenue, Net Income and Gross profit
  • Figure 35. Pro-lab Diagnostics(United States) Revenue: by Geography 2023
  • Figure 36. Global Legionella Testing: by Type USD Million (2025-2030)
  • Figure 37. Global Legionella Testing: by Application USD Million (2025-2030)
  • Figure 38. Global Legionella Testing: by End User USD Million (2025-2030)
  • Figure 39. South America Legionella Testing Share (%), by Country
  • Figure 40. Asia Pacific Legionella Testing Share (%), by Country
  • Figure 41. Europe Legionella Testing Share (%), by Country
  • Figure 42. MEA Legionella Testing Share (%), by Country
  • Figure 43. North America Legionella Testing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Beckman Coulter (United States)
  • Bio-Rad Laboratories (United States)
  • Abbott (United States)
  • Roche Diagnostics (Switzerland)
  • Thermo Fischer Scientific(United States)
  • Becton, Dickinson (BD) (United States)
  • BioMerieux(France)
  • Eiken Chemical(Japan)
  • Hologic (United States)
  • Pro-lab Diagnostics(United States)
Additional players considered in the study are as follows:
QIAGEN (United States) , Takara Bio(Japan)
Select User Access Type

Key Highlights of Report


Apr 2024 237 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Legionella Testing Quantitative research analysis
Global Legionella Testing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Beckman Coulter (United States), Bio-Rad Laboratories (United States), Abbott (United States), Roche Diagnostics (Switzerland), Thermo Fischer Scientific(United States), Becton, Dickinson (BD) (United States), BioMerieux(France), Eiken Chemical(Japan), Hologic (United States) and Pro-lab Diagnostics(United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancements in the Field of Bacterial Testing" is seen as one of major influencing trends for Legionella Testing Market during projected period 2023-2030.
The Legionella Testing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Legionella Testing Report?

Have a Query? Click Here

Other Related Reports

Chemotherapy Induced Peripheral Neuropathy Treatment Comprehensive Study by Type (APX-3330, BR-297, Cannabidiol, Dimiracetam, Others), Application (Platinum Agents, Taxanes, Vinca Alkaloids, Others) ...
$ 3500
Animal Therapeutics and Diagnostics Comprehensive Study by Type (Animal Diagnostics Products (Instruments, Consumables), Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Infla...
$ 3750
Irritable Bowel Syndrome Treatment Comprehensive Study by Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Ramosetron Hydrochloride, Others), Distribution Channel (Hospital Pharmacies, Online...
$ 3450
Cancer Test Comprehensive Study by Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), Application (Bladder Cancer Test, Breast Cancer Test, Cervical Cancer Test, Colorectal (Colon) Cancer Te...
$ 3650
Dermatological Therapeutics Comprehensive Study by Type (Anti-infectives , Corticosteroids, Anti Psoriasis, Anti-acne , Others), Application (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopec...
$ 3750
Thyroid Cancer Treatment Comprehensive Study by Type (Surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs), Application (Hospitals, Oncology centers, Hospital Phar...
$ 3650